Biostage (BSTG) Tops Q2 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. SPY
9. XYZ
10. FISV

Go back to Biostage (BSTG) Tops Q2 EPS by 4c

Biostage Reports 2016 Second Quarter Financial Results and Provides Business Update Outlining Key Near-term Milestones

August 11, 2016 7:27 AM EDT

HOLLISTON, Mass., Aug. 11, 2016 /PRNewswire/ -- Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the esophagus, bronchus and trachea, today announced financial results for the three months ended June 30, 2016. The Company also reviewed recent corporate highlights and provided an update on expected near-term milestones. As previously announced, Biostage management will host a business update conference call and live webcast, with accompanying presentation slides, for... More